Coya Therapeutics Inc stock is traded at $3.21, with a volume of 89,967. It is up +1.58% in the last 24 hours and down -33.26% over the past month. Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Previous Close:
$3.16
Open:
$3.29
24h Volume:
89,967
Relative Volume:
0.39
Market Cap:
$75.30M
Revenue:
$7.94M
Net Income/Loss:
-$21.13M
P/E Ratio:
-
EPS:
-$1.08
Net Cash Flow:
-$16.17M
1W Performance:
+14.23%
1M Performance:
-33.26%
6M Performance:
-25.17%
1Y Performance:
-47.29%
1-Day Range:
$3.17$3.39
1-Week Range:
$2.74$3.47
52-Week Range:
$2.72$6.62
Coya Therapeutics Inc Stock (COYA) Company Profile
Name
Coya Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
650.739.3939Address
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS